Connect
MJA
MJA

Cardiovascular diseases

Medical education / Snapshot

Pulmonary tumour thrombotic microangiopathy: a rare but underappreciated complication of malignancy

Pakeeran Siriratnam and Vishal Boolell

Med J Aust 2019; 211 (6): 257-257.e1

Editorials

Socio‐economic disadvantage and cardiovascular risk factors in young Aboriginal and Torres Strait Islander Australians

Katherine A Thurber and Katy JL Bell

Med J Aust 2019; 211 (6): 259-260 Free

Research

The Australian Aboriginal Birth Cohort study: socio‐economic status at birth and cardiovascular risk factors to 25 years of age

Markus Juonala, Pauline Sjöholm, Katja Pahkala, Susan Ellul, Noora Kartiosuo, Belinda Davison and Gurmeet R Singh

Med J Aust 2019; 211 (6): 265-270 Free

Perspectives

Primary prevention implantable cardioverter defibrillators in non‐ischaemic cardiomyopathy: challenging the Australian heart failure guidelines

Dennis H Lau, Jonathan M Kalman and Prashanthan Sanders

Med J Aust 2019; 211 (4): 154-155.e1

Letters

Adjunctive bacteriophage therapy for prosthetic valve endocarditis due to Staphylococcus aureus

Timothy Gilbey, Josephine Ho, Louise A Cooley, Aleksandra Petrovic Fabijan and Jonathan R Iredell

Med J Aust 2019; 211 (3): 142-143.e1

Letters

Call for a national sore throat guideline

Adrian J Tarca, Robert M Hand and Rosemary Wyber

Med J Aust 2019; 210 (10): 477-477.e1

Study protocol

Evaluating patients presenting to the emergency department after syncope: validation of the Canadian Syncope Risk Score

Jason Chan, Jonathan Hunter, Douglas Morel, Emma Ballard, David Brain, Alan Yan and Julia Hocking

Med J Aust 2019; 210 (11): 507-508.e3 Free

Research

Slower increase in life expectancy in Australia than in other high income countries: the contributions of age and cause of death

Alan D Lopez and Tim Adair

Med J Aust 2019; 210 (9): 403-409 Free

Narrative reviews

Advances in stroke medicine

Bruce CV Campbell

Med J Aust 2019; 210 (8): 367-374

Research

Evaluating recruitment strategies for AUSPICE, a large Australian community‐based randomised controlled trial

Roseanne Peel, Shu Ren, Alexis Hure, Tiffany‐Jane Evans, Catherine A D'Este, Walter P Abhayaratna, Andrew M Tonkin, Ingrid Hopper, Amanda G Thrift, Christopher R Levi, Jonathan Sturm, David Durrheim, Joseph Hung, Tom G Briffa, Derek P Chew, Phil Anderson, Lynelle Moon, Mark McEvoy, Philip M Hansbro, David A Newby and John R Attia

Med J Aust 2019; 210 (9): 409-415 Free

Narrative reviews

An updated review of lipid‐modifying therapy

Leon A Simons

Med J Aust 2019; 211 (2): 87-92

Editorials

Rapid access clinics for patients with chest pain: will they work in Australia?

Clara K Chow and Adam Timmis

Med J Aust 2019; 210 (7): 307-308

Narrative reviews

Coexisting chronic obstructive pulmonary disease and cardiovascular disease in clinical practice: a diagnostic and therapeutic challenge

Paul Leong, Martin I Macdonald, Brian S Ko and Phil G Bardin

Med J Aust 2019; 210 (9): 417-423

Medical education / Snapshot

Carotid sinus hypersensitivity

Vahid Moosavi and Mohammad Paymard

Med J Aust 2019; 210 (6): 257

Research

Evaluating the benefits of a rapid access chest pain clinic in Australia

James Andrew Black, Kevin Cheng, Jo‐Anne Flood, Garry Hamilton, Serena Parker, Anees Enayati, Faisal S Khan and Tom Marwick

Med J Aust 2019; 210 (7): 321-325 Free

Editorials

Developing cardiovascular risk prediction models for Australia

Mark R Nelson and Mark Woodward

Med J Aust 2019; 210 (4): 158-159

Editorials

Engaging GPs and primary care patients in research: implications of the ASPREE trial for future studies

James P Sheppard and Chris Butler

Med J Aust 2019; 210 (4): 159-160

Research

External validation and comparison of four cardiovascular risk prediction models with data from the Australian Diabetes, Obesity and Lifestyle study

Loai Albarqouni, Jennifer A Doust, Dianna Magliano, Elizabeth LM Barr, Jonathan E Shaw and Paul P Glasziou

Med J Aust 2019; 210 (4): 161-167 Free

Research

Intensive lipid‐lowering therapy in the 12 months after an acute coronary syndrome in Australia: an observational analysis

David Brieger, Mario D'Souza, Karice Hyun, James C Weaver and Leonard Kritharides

Med J Aust 2019; 210 (2): 80-85 Free

Editorials

Reducing cardiovascular risk in people with diabetes and kidney disease

Brendon L Neuen and Vlado Perkovic

Med J Aust 2018; 209 (10): 438-439

Research

Type 2 diabetes in patients with end-stage kidney disease: influence on cardiovascular disease-related mortality risk

Wai H Lim, David W Johnson, Carmel Hawley, Charmaine Lok, Kevan R Polkinghorne, Matthew A Roberts, Neil Boudville and Germaine Wong

Med J Aust 2018; 209 (10): 440-446 Free

Letters

Absolute cardiovascular disease risk and lipid-lowering therapy among Aboriginal and Torres Strait Islander Australians

Rosalie Schultz

Med J Aust 2018; 209 (8): 369

Letters

Absolute cardiovascular disease risk and lipid-lowering therapy among Aboriginal and Torres Strait Islander Australians

Raymond W Lovett

Med J Aust 2018; 209 (8): 368-370

Perspectives

The rising health, social and economic costs of Australia’s ageing prisoner population

Natasha A Ginnivan, Tony G Butler and Adrienne N Withall

Med J Aust 2018; 209 (10): 422-424

Perspectives

Public reporting of percutaneous coronary interventions

David Enze Wang, Rishi K Wadhera and Deepak L Bhatt

Med J Aust 2018; 209 (3): 104-105